Goodwin advised Otta on its sale to Welcome to the Jungle. French branding and recruitment platform Welcome to the Jungle announced the acquisition of London-based job search...
You must be a Standard 1 Year member to access this content.
Goodwin advised Lowercarbon Capital on the investment in Breathe Battery. Breathe Battery Technologies Limited secured a $10 million Series A funding round, led by Lowercarbon Capital...
You must be a Standard 1 Year member to access this content.
Kyowa Kirin was represented by Goldman Sachs Japan Co., Ltd. as financial advisor and Morrison & Foerster LLP. as legal advisor. Orchard Therapeutics was represented by...
You must be a Standard 1 Year member to access this content.
Bird & Bird advised Lonza, while Goodwin and NautaDutilh advised Synaffix. SynAffix B.V. announced the sale to Lonza Group AG. Under the terms of the sale and...
You must be a Standard 1 Year member to access this content.
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Insempra on the deal. Insempra announced its strategic investment into Solena Materials Ltd (“Solena”) a synthetic biology company. Solena, a spin-out from Imperial College...
You must be a Standard 1 Year member to access this content.
Goodwin advised Syndesi Therapeutics on the deal. Deloitte Legal assisted the selling shareholders and the company with the sale of Syndesi Therapeutics. Syndesi annouunced its acquisition by...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Omega Funds on the deal. Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company exploiting a broad DDR-based platform and small...
You must be a Standard 1 Year member to access this content.
